Every other small bio finds a way to get EU or FDA trials underway and goes the proper route.
I always cringed and I should have known better, when these guys constantly ignored those standard routes in favor of these bs Bulgarian and Africa ones. I said a year ago that ITV-1 might be going the same amateur hour disaster route that the IPF launch did and sure enough that’s what happened. Nothing but excuses from day 1, “soon”s and delays. Now we might be lucky a year from now to see Africa results.
Still have no clue why they didn’t focus on Clone 3 from the beginning. If the science works, finding a way to EU or FDA trials shouldn’t be an issue.
Just give up already Charles, take a damn buyout and hand this companies portfolio over to someone who’s competent and can handle it the right way to market.
News 
Market Data 
Discover 
